首页> 外国专利> CD8+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS OF THE HUMAN GASTROINTESTINAL TRACT

CD8+ REGULATORY T-CELLS FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS OF THE HUMAN GASTROINTESTINAL TRACT

机译:CD8 +调节性T细胞,用于治疗人类胃肠道炎性疾病

摘要

The present invention relates to composition comprising an isolated CD8+ Treg cell population, wherein the Treg cells have signatures for i) identifying that the T-cells are CD8+ regulatory Tcells, ii) identifying that the Treg cells are tissue type tropic, i.e they can migrate to the diseased tissue, iii) optionally identifying that the Treg cells are tropic with respect to the diseased tissue, i.e. they are homing cells, iv) identifying that the Treg cells are emigrant cells, i.e. they originate from the target tissue, and v) optionally identifying that the Treg cells are capable of being retained in the target tissue and optionally one or more X-signatures and/or one or more Y-signatures.
机译:本发明涉及包含分离的CD8 + Treg细胞群的组合物,其中所述Treg细胞具有以下特征:i)识别所述T细胞为CD8 +调节性T细胞,ii)识别所述Treg细胞为组织型,即它们可以迁移iii)任选地鉴定Treg细胞相对于患病组织是嗜性的,即它们是归巢细胞,iv)鉴定Treg细胞是移殖细胞,即它们源自靶组织,并且v)任选地鉴定Treg细胞能够被保留在靶组织中以及任选地一种或多种X签名和/或一种或多种Y签名。

著录项

  • 公开/公告号EP3131559B1

    专利类型

  • 公开/公告日2019-02-13

    原文格式PDF

  • 申请/专利权人 GENOVIE AB;

    申请/专利号EP20150717163

  • 发明设计人 JARVIS REAGAN MICHEAL;THÖRN MAGNUS;

    申请日2015-04-16

  • 分类号A61K35/14;C12N5/0783;A61K35/17;A61K47/02;A61K9/08;G01N33/569;

  • 国家 EP

  • 入库时间 2022-08-21 12:29:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号